Health & Fitness COVID Vaccine Experience and your preference.

Which COVID Vaccine did you get or are planning to get

  • Already Received Covishield

    Votes: 49 68.1%
  • Already Received Covaxin

    Votes: 6 8.3%
  • Want to get Covishield

    Votes: 4 5.6%
  • Want to get Covaxin

    Votes: 4 5.6%
  • Want to get Sputnik V

    Votes: 3 4.2%
  • Want to get Pfizer,Moderna, other mRNA base Vaccines

    Votes: 10 13.9%
  • Already Received Pfizer , Moderna , other mRNA based vaccines

    Votes: 2 2.8%
  • Already Received Sputnik V

    Votes: 0 0.0%
  • Scared as hell to step out even for vaccine.

    Votes: 2 2.8%

  • Total voters
    72

Marcus Fenix

Well-Known Member
Skilled
Received Covishield 1st dose yesterday (Age 33).
Felt weak in the evening yesterday.
Weakness continued today with slight ache on left arm where I got the shot. No fever so far.
 

puns

Well-Known Member
Staff member
Received Covishield 1st dose yesterday (Age 33).
Felt weak in the evening yesterday.
Weakness continued today with slight ache on left arm where I got the shot. No fever so far.

exactly this for me as well. only little older :D
 

Marcus Fenix

Well-Known Member
Skilled
Don't get scared by this at this point about COVAXIN without more evidence. If the vaccinated person is not exposed to a threshold amount of COVID19 virus sufficient volume of antibody might not be generated.

WHO is validating the COVAXIN trial data at this point. Hopefully they will figure it out.

 

NotMyRealName

Well-Known Member
Skilled
If the vaccinated person is not exposed to a threshold amount of COVID19 virus sufficient volume of antibody might not be generated.
Not sure what you meant by this. Exposure to an actual covid infection?
This article was about the antibody titre. Comparison between covishield any covaxin. It also says the titre may have no bearing on actually efficacy. This is just some data, can't come to any conclusion without more data.

That said i would prefer covishield to covaxin simply because it's based on AZ which has more studies done worldwide. Tomorrow if covaxin can conclusively prove better efficacy through reliable data, i will simply prefer that instead.
 

Marcus Fenix

Well-Known Member
Skilled
Not sure what you meant by this. Exposure to an actual covid infection?
This article was about the antibody titre. Comparison between covishield any covaxin. It also says the titre may have no bearing on actually efficacy. This is just some data, can't come to any conclusion without more data.
Exposure to the virus will lead to antibody generation for non-vaccinated folks who were exposed to the virus but survived the bout.

Remember the Dharavi study last year which saw that more than half of the population had antibodies.

Some vaccines might induce the body to produce antibodies from the get go whereas some get invoked when the actual antigen i..e virus is detected.

Covishield has a higher titre than COVAXIN but its not conclusive as COVAXIN might generate more if exposed to COVID virus. This might be the case as COVAXIN is an inactivated vaccine and doesn't have much of an imunno response which bugged the hell out of quaratineinthesejeans.. But again like you said COVAXIN is a bit of a black box as of now.


Please do note that I am a noob in this regard and would defer to the actual pros e.g. @quaratineinthesejeans .
 

quaratineinthesejeans

Justiceforall
Skilled
Yes, not only me, it's bugging everyone. First nobody knows if the anti spike antibodies are protective or not ( if protective there must be a primary rise following at least natural infection, but all the studies measuring this antibody found out that the response is non linear, even studies with non random samples couldn't find a linear relation with time from recovery.
By studies, I mean those give us access to their all raw data and clearly mention sampling techniques used.
With genuine random sampling the antibody responses are all scattered ( beyond any semi conclusive range)
I actually tried to make a list of antibody response studies submitted to us ( only 6 has proper random sampling, only two with more than 500 sample size)
It's totally blurry to me from statistical POV.

But one thing is clear ( with strong statistical correlations) All the vaccines used today prevent serious disease ( CT and few clinical and laboratory values) incuding Covaxin. Bharat Biotech did send us some useful data ( but for some reason they haven't included approximate geolocation... don't know why...it's very important specially when their genomic sequencing data is practically non existent...it's very sparse from India, there is no way we can predict efficacy against newer strains.
If they could give us some broad location ( at least cities/ districts) we could still calculate something from the strain mapping indirectly (definitely not very accurate, but better than nothing)

Bharat Biotech's data collection was somewhat different ( and under given circumstances, rather intelligent/ interesting) instead of giving much importance on antibody response, clinical symptoms ( with or without RT PCR positivity) were taken into account. Though it pissed microbiologists, it's a nice approach from public health point of view ( they assumed 90-93 percent of adult symptomatic patients, without CT scan or RT PCR to be positive, did an absolutely brilliant calculation with available seasonal flu prevalence during the months of study in an area to come to those percentages....really high grade stuff.. everyone knows basic statistics, but how one uses it to improvise logically defines good statistician...it would have a really breakthrough paper alone if they could give the locations of study population...which they obviously have and used, but didn't give the raw data)
I felt proud for Indian statisticians after a long time. It shows, this country still has top notch people.
 
Last edited:

Nalin

Well-Known Member
Skilled
29
1st dose of Covishield on 5 June, 2021
Fever (101) for a day along with chills and body ache
 

TheCoolerPlayer

Well-Known Member
Disciple
Received covishield today (as part of our CHS being offered place for vaccination at ₹850)
Age under 20
Patiently waiting for fever to kick in :p

29
1st dose of Covishield on 5 June, 2021
Fever (101) for a day along with chills and body ache
@Nalin 's experience mirrors mine, except had 101 fever, chills and body ache for almost 2 days - till yesterday noon.
 

Marcus Fenix

Well-Known Member
Skilled
I took a total of 3 paracetamol as well, but at a gap of 10-12 hours. Btw is taking paracetamol advisable after taking a vaccine @quaratineinthesejeans? I didn't want to take it but parents insisted on it :/
Its okay as per two of my cousins who are doctors.

One of them had high fever after 1st dose back in Feb. He recommended to go for Paracetamol 650. 500 is good enough in this case.

I am more or less okay today(1st dose on Saturday).
 
Top